$3698 | SAVE $652 | Site License
$8075 | SAVE $1,425 | Global License

World Rubella Diagnostics Market: Emerging Opportunities and Growth Strategies
[Report Updated: 12-07-2016]

Published by Venture Planning Group (VPG): 12 Jul 2016 | 59609 | In Stock
Related Topics: Antibodies , Public Health

Introduction

The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Rubella tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 235 pages and 15 tables

Table of Contents
for World Rubella Diagnostics Market: Emerging Opportunities and Growth Strategies [Report Updated: 12-07-2016]

  • Table of Content - click REQUEST A SAMPLE BUTTON

List Of Tables
in World Rubella Diagnostics Market: Emerging Opportunities and Growth Strategies [Report Updated: 12-07-2016]

Competitive Assessments

- Abbott

- Affymetrix

- Beckman Coulter/Danaher

- Becton Dickinson

- bioMerieux

- Bio-Rad

- Cepheid

- Diamedix

- DiaSorin

- Eiken Chemical

- Elitech Group

- Enzo Biochem

- Fujirebio

- Grifols

- Hologic/Gen-Probe

- ID Biomedical/GSK

- Kreatech/Leica

- Lonza

- Ortho-Clinical Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Takara Bio

- Thermo Fisher/Life Technology

- Wallac/PE

- Wako

Additional Details

Publisher

Venture Planning Group (VPG)

Publisher Information

Reference

59609 | VPID19685

Number of Pages

235

Report Format

PDF

Venture Planning Group (VPG) Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! W.O.M. World Of Medicine GmbH - Strategic SWOT Analysis Review
W.O.M. World Of Medicine GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into...
10 May 2016 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Harnessing The Power Of Real World Data
Introduction....IntroductionHow to collect and interpret the real world data that supports your bran...
01 Jan 2016 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Avvaa World Health Care Products, Inc. (AVVH) - Financial and Strategic SWOT Analysis Review
SummaryAvvaa World Health Care Products, Inc. (Avvaa) is a biotechnology company, based in Canada. T...
08 Nov 2015 by Global Data USD $255 (normally
USD $300)
More Info
SAVE 15% today! World Enzymes Market - Opportunities and Forecasts, 2014 -2020
Enzymes have gathered a special attention in the recent years due to its potential application in th...
01 Sep 2015 by Allied Market Research USD $3,838 (normally
USD $4,515)
More Info
SAVE 15% today! World Cardiac Biomarkers Market - Opportunities and Forecasts, 2014 -2020
The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing ...
01 Aug 2015 by Allied Market Research USD $3,838 (normally
USD $4,515)
More Info
SAVE 15% today! World Smart Pills Technology Market - Opportunities and Forecasts, 2014 - 2020
Smart pill technology is a revolutionary technological innovation that has reduced the gap between h...
01 Aug 2015 by Allied Market Research USD $3,838 (normally
USD $4,515)
More Info
SAVE 15% today! Physician Views – Are oncologists ready to embrace real-world data?
Scope As pharma looks to both improve the efficiencies of its operating models and deliver more comp...
15 Apr 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Strategies for Working With Real World Data
IntroductionReal world data (RWD)—it’s a never-ending wave of information that is, increasingly, tra...
01 Oct 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Closing the Loop: delivering real-world commercial benefit from closed-loop marketing
IntroductionYour step-by-step guide to adapting to real time change.Over the past decade, closed loo...
01 Jan 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Managing Real World Data
IntroductionPharma companies are no longer the sole owners and controllers of the information that d...
01 Oct 2012 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by Venture Planning Group (VPG)

Download Free Report Summary PDF

World Rubella Diagnostics Market: Emerging Opportunities and Growth Strategies [Report Updated: 12-07-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...